RELATED SUBSTANCE METHOD DEVELOPMENT AND VALIDATION OF LOXAPINE SUCCINATE IN CAPSULE DOSAGE FORM BY REVERSE PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

  • KHUSHBU A THAKOR Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy and Research, Parul University, Vadodara, Gujarat, India.
  • PASHA TY Department of Pharmaceutical Chemistry, Parul Institute of Pharmacy and Research, Parul University, Vadodara, Gujarat, India.

Abstract

Objective: The present study gives a simple, rapid, and accurate stability indicating reverse phase high-performance liquid chromatography method for the determination of loxapine succinate and its related substance (related compound A) in capsule dosage form.


Methods: Loxapine succinate and its related substance were attained on a C18 Purospher star (250 mm × 4.6 mm, 5 μm particle size) column at 254 nm detection wavelength, 1.0 ml/min as a flow rate, and 10 μl injection volume. Water:methanol: Triethylamine: Tetrahydrofuran (50:40:1:10) was used a mobile phase, and column oven temperature was 30°C.


Results: The resolution between loxapine succinate and known unknown impurities was >2.0. The correlation coefficient (0.999) value indicates the linear relationship between the concentration and peak areas. The accuracy study was performed by spiking method. Loxapine succinate was exposed to the stress condition of hydrolysis (acid and base), oxidative, thermal, and photolytic degradation. Loxapine succinate was found to degrade unquestionably in acid and base stress condition and almost stable in oxidative, thermal, and photolytic conditions.


Conclusion: The degradant products were well resolved from leading peak and its related compound A peak and any other unknown peak justifying the stability indicating capability of the method. The developed method was validated as per the ICH guidelines. This method is used for periodic analysis in laboratory.

Keywords: Loxapine succinate,, Related substance,, Validation,, Reverse phase high-performance liquid chromatography,, ICH.

References

1. Barar FS. Essentials of Pharmacotherapeutics. 5th ed. New Delhi: S. Chand and Company Ltd.; 2011. p.143.
2. Tripathi KD. Essential of Medical Pharmacology. 5th ed. New Delhi: Jaypee Publisher; 1997. p. 394.
3. Hawland RD. Reviews: Pharmacology. 3rd ed. Philadelphia, PA: Lippincott’s Illustrated Reviews, B. I. Publications; 1996. p. 149.
4. Available from: http://www.drugbank.ca/drugs/DB00408. [Last accessed on 2019 Apr 13].
5. Available from: http://www.chemspider.com/chemicalstructure.3827. html. [Last accessed on 2019 Apr 15].
6. Available from: http://Pubchem.ncbi.nlm.nih.gov/compound/Loxapine. [Last accessed on 2019 Apr 11].
7. Available from: http://www.rsc.org/merck-index. [Last accessed on 2019 Apr 18].
8. The United State Pharmacopoeia Convention. <905> US Pharmacopeia 32 NF 27. Vol. 1. Rockville: The United State Pharmacopoeia Convention; 2005. p. 2817.
9. International Conference on Harmonisation. The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use Guidelines. Geneva, Switzerland: Stability Testing of New
Drug Substance and Products; 2003.
10. ICH Q2A. Validation of Analytical Method, November 2012; 2005.
11. ICH Q8 (R2). Pharmaceutical Development; 2009.
12. ICH Q9. Quality Risk Management; 2005.
13. ICH Q10. Pharmaceutical Quality System; 2008.
14. Ahuja S, Scypinski S. Handbook of Modern Pharmaceutical Analysis. United States of America: Academic Press; 2001. p. 349.
15. Rajendra P, Tushar D. Review on analytical method development and validation. J Pharm Anal 2014;3:1-10.
16. Skoog DA, Holler FJ. Nieman TA. An Introduction to Analytical Chemistry. 5th ed. Singapore: Thomson Brooks/Cole Publication; 1994. p. 566-8.
17. Sharma BK. Instrumental Methods of Chemical Analysis. 23rd ed. New Delhi: Goel Publication House; 2002. p. 1-16.
18. Jeffery G, Bassett J, Mehdham J, Denney R. In Text of quantitative Chemical Analysis. 5th ed. Harlow, Essex, England, New York: Longman Scientific & Technical, Wiley; 1989. p. 34.
19. Snyder L, Kirkland J. Introduction to Modern Liquid Chromatography. 2nd ed. New York: John Wiley & Sons Inc.; 1997. p. 267-400.
20. U.S. Department of Health and Human Services Food and Drug Administration. Guidance for Industry: Analytical Procedures and Methods Validation of Drugs and Biologics. U.S. Department of Health and Human Services Food and Drug Administration; 2015. p. 1-13.
21. Bakshi M, Singh S. Development of validated stability-indicating assay methods – critical review. J Pharm Biomed Anal 2002;28:1011-40.
22. Bhojan C. Development of UV spectrophotometry and HPTLC techniques for loxapine in formulation. Int J Chem Pharm Anal 2017;4:12-7.
23. Dammalapati S, Rudraraju R. Development and validation of RP-HPLC method for loxapine in capsule dosage form. Int J Adv Pharm Anal 2015;5:61-4.
24. Garay Garcia L, Forfar-Bares I, Pehourcq F, Jarry C. Simultaneous determination of four antipsychotic drugs in plasma by high-performance liquid chromatography. Application to management of acute intoxications. J Chromatogr B Analyt Technol Biomed Life Sci 2003;795:257-64.
Statistics
191 Views | 55 Downloads
How to Cite
KHUSHBU A THAKOR, and PASHA TY. “RELATED SUBSTANCE METHOD DEVELOPMENT AND VALIDATION OF LOXAPINE SUCCINATE IN CAPSULE DOSAGE FORM BY REVERSE PHASE HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 12, no. 7, May 2019, pp. 203-7, https://innovareacademics.in/journals/index.php/ajpcr/article/view/33746.
Section
Original Article(s)